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Abstarct : Changes in the generation of leukotrienes B4 (LTB4) and C4 (LTC4) by
leucocytes after spa therapy were examined in 30 patients with asthma. 1. The effi-
cacy of spa therapy was marked in 8 (26.7%), and moderate in 16 (53.3%) of 30
patients with asthma, and slight or no efficacy of the therapy was observed in the re-
sidual 6 patients (20.0%). 2. Bronchial reactivity to methacholine was the highest in
patients with slight or no efficacy of spa therapy, however. there were no significant
differences among the three groups classified by clinical efficacy. 3. The generation of
LTC4 was significantly higher in patients with slight or no efficacy compared with the
generation in those with marked (p<O. 01) and moderate efficacy (p<O. 001). However,
there were no signifcant differences in the generation of LTB4 among them. 4. The
generation of LTC4 signifcantly decreased in patients with marked and moderate effi-
cacy after spa therapy. but not in those with slight or no efficacy. The generation of
LTB4 was not significantly different before and after spa therapy among patients with
marked, moderate, and slight or no efficacy. These results show that the efficacy of
spa therapy for patients with asthma is closely related to the generation of LTC4 by
leucocytes.
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Introduction
Bronchial asthma is a disease characterized
by bronchial hyperresponsiveness associated
with airway inflammation. In onset mechanisms
of asthma, bridging of IgE receptors on mast
cell membrane is caused by allergen, followed
by the release of chemical mediators such as
histamine and leukotrienes B4 (LTB4) and C4
(LTC4) l, 2). These chemical mediators induce
pathophysiological changes of airways such as
bronchoconstriction, mucus hypersecretion and
edema of mucous membrane. Thus, chemical
mediators play an important role in the trigger-
ing events of asthma attacks.
Spa therapy has been reported to be effective
for patients with asthma3-5), particularly for
steroid-dependent asthma6 • 7). In analysis of ac-
tion mechanisms of spa therapy for asthma, it has
been demonstrated that ventilatory function is
improved by direct action of spa therapy8,9 1,
and the effects on suppressed function of
adrenocortical glandslO), endocrine-autonomic
nerve systemlll , and psychological factorsl2) have
been observed as indirect action of spa therapy.
Our previous studies have shown that the
generation of LTB4 by leucocytes was signifi-
cantly larger in patients with spa efficacy than in
those without efficacyl3) . The generation of LTC4
in patients with spa efficacy was larger com-
pared to the generation in those without efficacy;
however, the difference was not significant.
These results suggest that spa efficacy for
patients with asthma is related to a certain ex-
tent to the generation of LTB4 and LTC4 by
leucocytes.
In the present study, changes in the genera-
tion of LTB4 and LTC4 by leucocytes after spa
therapy was examined in patients with asthma
in relation to spa efficacy.
Subjects and Methods
The subjects in this study was 30 patients (19
females and 11 males) with asthma. Their
mean age was 59. 1 years (range 27 to 74 years) .
The mean level of serum IgE was 555 IU/ ml
(range 25-5195 IU/ml). All of them had a
complex spa therapy comprised of swimming
training in a hot spring pool, fango therapy,
and inhalation with iodine salt solution for one
to three months 7) •
The efficacy of spa therapy was assessed
by comparing their symptoms before and after
spa therapy. The efficacy was estimated in four
degrees; marked, moderate, and slight or no
efficacy, and in subjects in whom marked and
moderate efficacy was shown, spa therapy was
evaluated as being effective. The spa efficacy
was analyzed in relation to brobchial
hyperresponsiveness to methacholine and the
generation of leukotrienes B4 (LTB4) and C4
(LTC4) by leucocytes.
Bronchial hyperresponsiveness to· methacholine
was measured by an Astograph (TCK 6100,
Chest Co), as previously described141 • All medi-
cations were stopped 12 hours prior to exa-
mination. A methacholine concentration causing
a significant increase in total respiratory resis-
tance (Rrs) was assessed as Cmin (minimum
concentration) .
Ventilatory function test using a Box Spiror
81-S were carried out in all subjects when they
were attack-free.
The amount of LTB4 and LTC4 generated by
the peripheral leucocytes were assessed accord-
ing to the folowing procedurelS). A quarter vol-
ume of 6 % dextran was added to 20 ml of
peripheral blood, and this was left for 1 hour
at room temperature. The leucocyte-rich plasma
supematant was then removed and used. The
LTB4 and LTC4 in asthma and spa therapy 40
number of cells was adjusted to 5x106 cells/mL
in Tris CM buffer, and 1 fL g of calcium
ionophore A23187 (Sigma St Louis, Mo) was
then added to the cell suspension. The solution
was mixed and incubated for 15 min at 37"C.
After a 4x volume of prechilled ethanol (final,
80% ethanol) was added, this was centrifuged
at 3000 rpm for 30 min. A syringe filter
(Toyo Roshi Co, Tokyo) was used to draw the
supematant, and the filtrate was decompressed
and dried to a solid. Quantification of LTB4 and
LTC4 was performed by HPLC and DV spe
ctroscopy, with the method of Lam et al16).
Quantities of LTB4 and LTC4 were expressed as
nanogram per 5xl06 cells.
The level of total IgE in serum were meas-
ured by radioimmunosorbent test (RIST) , and
specific IgE antibodies against inhalant allergens
were estimated by radioallergosorbent test (RA
ST).
Statistically significant differences of the mean
were evaluated using unpaired Student't test.
A p value of <0. 05 was regarded as significant.
Results
Table 1 shows the clinical effects of spa ther-
apy on asthma in relation to patient age and the
Table 1. Efficacy of spa therapy for patients with asthma,
patient age, and FEV1 .0%
Efficacy No of Age, years FEV1.0%patients
Marked 8 (26.7%) 52.0 70.0± 9.1
Moderate 16 (53.3%) 59.7 67.1 ±11.0
Slight or 6 (20.0%) 56.7 64.2±11.3No
value of FEVI. 0%. The efficacy of spa therapy
was marked in 8 (26.7%), moderate in 16 (53.
3%), and slight or no efficacy in 6 (20.0%) of
30 patients with asthma. The efficacy of spa
therapy was not related to age. The value of
FEVl. 0% was higher in patients with marked
and moderate efficacy than in those with slight
or no efficacy. However, this difference was not
significant. The serum IgE level was not corre-
lated with spa efficacy. The frequency of pa-
tients with positive RAST against inhalant
allergens was higher in patients with slight or
no efficacy of spa therapy than in those with
marked and moderate efficacy, however, the
difference was not significant (Table 2).
Table 2. Efficacy of spa therapy for patients with asthma
and IgE-mediated allergy
Efficacy No of IgE (IU/ml) Positivepatients RAST*
Marked 8 327 5/8 (62.5%)(25-1658)
Moderate 16 711 11/16 (68.8%)(36-5195)
Slight or 6 376 5/6 (83.3%)No (108-1124)
"Frequency of patients with positive RAST against
inhalant allergens
Bronchial hyperresponsiveness to methacholine
was lower in patients with slight or no efficacy
compared with that in those with marked effic-
acy, as shown in Fig. I.
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Fig.l Bronchial hyperresponslveness to methacholine in
patients with asthma in relation to clinical
efficacy
There were no significant differences in LTB4
generation among three groups classified by spa
41 LTB4 and LTC4 in asthma and spa therapy
efficacy. In contrast, the generation of LTC4
was significantly larger in patients with slight or
no efficacy than in those with marked (p<O.01)
and moderate efficacy (p<O.OO1) (Fig. 2) .
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Fig.2. Generation of LTB4 and LTC4 by leukocytes in patients
with asthma during non·attack stages in relation to
clinical efficacy. a: p<O.Ol, b :p<O.OOl.
The generation of LTB4 by leucocytes in
patients with marked efficacy was not signifi-
cantly different before and after spa therapy,
however, the generation of LTC4 by leucocytes
was significantly larger before spa therapy com-
pared to the generation after the therapy (Fig. 3) .
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Fig.3. Generation of LT84 and LTC4 by leukocytes in asthmatics
with marked efficacy before and after spa therapy.
a: p<O.OO1.
In patients with moderate efficacy of spa th-
erapy, the generation of LTC4 before spa
therapy was also significantly higher compared
to the generation after the therapy (p<O. 01),
but not the generation of LTB4 (Fig. 4).
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Flg.4. Generation of LTB4 and LTC4 by leukocytes In asthmatics
with moderate efficacy before and after spa therapy.
a: p<O.01.
In contrast, the generation of both LTB4 and
LTC4 did not significantly change before and
after spa therapy in patients with slight or
no efficacy (Fig. 5) .
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Fig.5. Generation of LT84 and LTC4 by leukocytes in asthmatics
with slight or no efficacy before and after spa therapy.
Discussion
Our previous studies have shown that spa
therapy is effective for patients with asthma 3 • 7) •
The direct actions of spa therapy improve clini-
cal symptoms3"5) and ventilatory functionS), and
suppress bronchial hyperresponsivenessl7) in
patients with asthma. The indirect actions of
spa therapy improve the function of the
adrenocortical glands1S).
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Bronchial asthma is characterized by transient
bronchoconstriction, accompanied with hyperse-
cretion and edema of mucous membrane.
Chemical mediators such as histamine, LTC4
and LTB4, which are released from tissue mast
cells during the time of immediate asthmatic
reaction (IAR) 19,20), and from inflammatory cells
during late asthmatic reaction (LAR), play an
important role in the onset mechanisms of
asthma attacks2!,22).
Effects of spa therapy on asthma are often
affectd by degrees of bronchial hyperresponsiv-
eness, release of chemical mediators such as
histamine and leukotrienes B4 and C4, and air-
way inflammatoion23).
Our previous studies have shown that the
generation of LTC4 in patients with spa efficacy
was larger compared with that in those without
efficacy, however, this difference was not sign-
ificant, and that the generation of LTB4 by
leucocytes was significantly larger in patients with
spa efficacy than in those without efficacy13).
The results also suggested that the release of
histamine from leucocytes was significantly
higher in patients without spa efficacy than in
those with efficacy. These results suggest that
spa efficacy is associated with the release of
histamine, LTB4 and LTC4 from leucocytes.
In the present study, a correlation between
the generation of LTB4 and LTC4 by leucocytes
and spa efficacy was examined in patients with
asthma in relation to asthmatic cycle. The
results revealed that. bronchial hyperresponsi-
veness was higher and the generation of LTC4
was significantly larger in patients without spa
efficacy than in those with marked and moder-
ate efficacy, but not the generation of LTB4.
These results do not agree with the results pre-
viously obtained, suggesting LTB4 was signifi-
cantly higher in patients with spa efficacy than
in those without efficacy. The difference might
be due to the different population of patients
studied; more atopic type asthma patients were
included in this study. Large amount of LTC4
generation before spa therapy significantly de-
creased in patients with marked and moderate
efficacy, but not in those without efficacy. The
results shows that spa therapy is less effective
in patients with large amount of LTC4 genera-
tion by leucocytes.
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気管支嘱息におけるロイコトリエンB4およびC
4産生,気管過敏性と温泉療法.
芦田耕三,光延文裕,保崎泰弘,柘野浩史,
岡本 誠,西田典数,高田異吾,横井 正,
谷崎勝朗
岡山大学三朝分院
気管支嶋息30例を対象に,温泉療法によるロイ
コトリエンB4 (uB4),C4 (LTC4)産生
の変動および気道過敏性と臨床効果との関連につ
いて検討を加えた｡1.温泉療法の臨床効果は,
著効8例 (26.7%),有効16例 (53.3%),やや有
効あるいは無効6例 (20.0%)であった｡2.メ
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サコリンに対する気道過敏性は,やや有効あるい
は無効例で高い傾向が見られたが,著効,有効例
と比べ有意の差は見られなかった03.IiTC4産
生はやや有効あるいは無効例において著効例 (P
<0.01)や有効例 (P<0.001)に比べ有意に高い
値が示された｡しかし,LTB4産生では臨床効果
との関連は見られなかった｡4.著効例および有
効例では,温泉療法後にu℃4産生の有意の低下
傾向が見られたが,無効例では有意の変動は見ら
れなかった.また,I:TB4産生に関しては温泉療
法の臨床効果にかかわらず有意の変動は見られな
かった｡これらの結果より,気管支嘱息に対する
温泉療法の臨床効果は,LTC4産生とある程度関
連していることを示唆しているものと考えられる｡
